bepmed |

P20012448
l 2001
GE

821. Tissue Plasminogen Activators (Improved Variants)

Abstract

1. Technical Result Increase in efficiency of vascular state or treatment of vascular diseases in mammals, widening of the assortment anticoagulants. 2. Essence By means...

13:59 / cells / methods

226941
l 2002
WO

822. PRIMITIVE NEURAL STEM CELLS AND METHOD FOR DIFFERENTIATION OF STEM CELLS TO NEURAL CELLS

Abstract

Described are a novel cell type in the neural lineage, and method of producing the same based on the degree of neural commitment and growth...

13:59 / cells / methods

216557
l 2002
WO

823. TISSUE ENGINEERING SCAFFOLDS PROMOTING MATRIX PROTEIN PRODUCTION

Abstract

Matrix-enhancing molecules, such as TGF- beta , are conjugated to or immobilized on scaffolds to increase ECM production by cells for tissue engineering, tissue regeneration...

13:59 / cells / Scaffolds

1440602
l 2002
AU

824. Tissue engineering logistics

Abstract

Year: 2002 Country: AU Doc No: 1440602 For more information visit espacenet.com Read more...

13:59 / cells / methods

2338440
l 2002
CA

825. FOAM COMPOSITE FOR THE REPAIR OR REGENERATION OF TISSUE

Abstract

The present patent describes a biocompatible composite made of a first fibrous layer attached to a three- dimensional inter-connected open cell porous foams that have...

13:59 / methods / Scaffolds

2391899
l 2002
CA

826. STERILIZATION OF BIOACTIVE COATINGS

Abstract

The invention provides a method for single-step surface modification, grafting and sterilization for bio-active coating on materials and biomaterials used in medical devices, such as...

13:59 / methods / Scaffolds

1165749
l 2002
EP

827. METHOD FOR PREPARING POROUS, BIODEGRADABLE AND BIOCOMPATIBLE, POLYMERIC SCAFFOLDS FOR TISSUE ENGINEERING

Abstract

Year: 2002 Country: EP Doc No: 1165749 For more information visit espacenet.com Read more...

13:59 / methods / Scaffolds

2001005592
l 2001
US

828. Chondrocyte-like cells useful for tissue engineering and methods

Abstract

Fibroblast cells are treated with a chemical inhibitor of protein kinase C such as staurosporine, in conjunction with functionally hypoxic micromass culture so as to...

13:59 / cells / methods

1233721
l 2002
EP

829. BIOACTIVE, DEGRADABLE COMPOSITE FOR TISSUE ENGINEERING

Abstract

Year: 2002 Country: EP Doc No: 1233721 For more information visit espacenet.com Read more...

13:59 / methods / Scaffolds

2001033857
l 2001
US

830. Porous tissue scaffoldings for the repair or regeneration of tissue

Abstract

The present patent describes a three-dimensional interconnected open cell porous foams that have a gradient in composition and/or microstructure through one or more directions. These...

13:59 / methods / Scaffolds

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract